[ad_1] (Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don’t stock the drug or make it easily available …
Read More »[ad_1] (Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don’t stock the drug or make it easily available …
Read More »